Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

NCT05426980 is registered in ClinicalTrials.gov with University of Ljubljana as lead sponsor.

NCT NCT05426980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05426980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study
Lead sponsor
University of Ljubljana
Phase
Observational
Overall status
Completed
Start date
December 13, 2021
Completion date
September 30, 2023
Enrollment
654 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis brain lesion, multiple sclerosis lesion